Cargando…

Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics

OBJECTIVE: To use systems biology to explore the biomolecular network mechanism of the Jiangtang Tiaozhi Recipe (JTTZR) in the intervention of obese Type 2 diabetes (T2DM) patients with dyslipidemia. METHODS: Twelve patients with obese type 2 diabetes mellitus and dyslipidemia (traditional Chinese m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Tingting, Wang, Song, Yang, Yingying, He, Lisha, Han, Lin, Zhai, Tiangang, Chen, Jia, Zhou, Qiang, Zhao, Xiyan, Lian, Fengmei, Zhao, Linhua, Tong, Xiaolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357946/ https://www.ncbi.nlm.nih.gov/pubmed/35957821 http://dx.doi.org/10.3389/fendo.2022.817147

Ejemplares similares

Efficacy and Mechanism of the Jiangtang Tiaozhi Recipe in the Management of Type 2 Diabetes and Dyslipidaemia: A Clinical Trial Protocol
por: Wu, Haoran, et al.
Publicado: (2022)

Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis
por: Huang, Ya-lan, et al.
Publicado: (2023)

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
por: Lan, Tian, et al.
Publicado: (2022)

Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data
por: Liu, Yi, et al.
Publicado: (2023)

Effects of Tiaozhi Granule on Regulation of Autophagy Levels in HUVECs
por: Wu, Ying-Ying, et al.
Publicado: (2018)

Treatment of Type 2 diabetes with Tianqi Jiangtang Capsule: A systematic review and meta-analysis of randomized controlled trials
por: Piao, Chunli, et al.
Publicado: (2020)

Jiangtang Tongmai Prescription Reduced Diabetic Lung Injury Through SnoN and TGF-β1/Smads Signaling Pathway
por: Ding, Nian, et al.
Publicado: (2022)

An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Zuogui Jiangtang Shuxin Formula in Diabetic Cardiomyopathy
por: Huang, Yalan, et al.
Publicado: (2023)

Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial
por: Kang, Xiaomin, et al.
Publicado: (2023)

Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study
por: Zhang, Yuqing, et al.
Publicado: (2022)

Jiangtang Sanhao formula ameliorates skeletal muscle insulin resistance via regulating GLUT4 translocation in diabetic mice
por: Ye, Zimengwei, et al.
Publicado: (2022)

Gut microbiota is a potential goalkeeper of dyslipidemia
por: Lei, Lirong, et al.
Publicado: (2022)

Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis
por: Yin, Xiangjun, et al.
Publicado: (2023)

Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence
por: Li, Xuewen, et al.
Publicado: (2022)

Identifying advanced MAFLD in a cohort of T2DM and clinical features
por: Sanchez-Bao, Ana Maria, et al.
Publicado: (2023)

High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study
por: Wang, Jie, et al.
Publicado: (2022)

Role of the Gut in Diabetic Dyslipidemia
por: Stahel, Priska, et al.
Publicado: (2020)

Efficacy of Chinese Herbal Medicine in the Treatment of Moderate-Severe Painful Diabetic Peripheral Neuropathy: A Retrospective Study
por: Zheng, Yujiao, et al.
Publicado: (2019)

Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula
por: Xu, Jia, et al.
Publicado: (2015)

To Investigate the Potential Mechanism of Huanglian Jiangtang Formula Lowering Blood Sugar in View of Network Pharmacology and Molecular Docking Technology
por: Li, Fang xu, et al.
Publicado: (2023)

Effects of Extracts from Tiaozhi Granule and Its Components on Expression of Scavenger Receptor Class B Type I
por: Yu, Xiao, et al.
Publicado: (2016)

Zebrafish Models for Dyslipidemia and Atherosclerosis Research
por: Schlegel, Amnon
Publicado: (2016)

Identification of Up-Regulated ANXA3 Resulting in Fracture Non-Union in Patients With T2DM
por: Liu, Changjiang, et al.
Publicado: (2022)

TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis
por: Li, Meng, et al.
Publicado: (2022)

Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
por: Zhang, Peng-Xiang, et al.
Publicado: (2022)

Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
por: Hong, Jinni, et al.
Publicado: (2023)

Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia
por: Xiao, Guanlin, et al.
Publicado: (2022)

Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy
por: Yang, Cunqing, et al.
Publicado: (2023)

Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review
por: Vukovic, Rade, et al.
Publicado: (2019)

The crucial role and mechanism of insulin resistance in metabolic disease
por: Zhao, Xuefei, et al.
Publicado: (2023)

Low-normal serum unconjugated bilirubin levels are associated with late but not early carotid atherosclerotic lesions in T2DM subjects
por: Jin, Chun-Hua, et al.
Publicado: (2022)

The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against‐Non-Alcoholic Steatohepatitis
por: Hong, Wei, et al.
Publicado: (2020)

GLP-1 based therapeutics: simultaneously combating T2DM and obesity
por: Heppner, Kristy M., et al.
Publicado: (2015)

Gut microbiota: A new target for T2DM prevention and treatment
por: Liu, Lulu, et al.
Publicado: (2022)

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023)

The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications
por: Zhang, Ziwei, et al.
Publicado: (2023)

The effect of Central and peripheral thyroid resistance indices on diabetic retinopathy: a study of hospitalized euthyroid patients with T2DM in China
por: Zhao, Xin, et al.
Publicado: (2023)

Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies
por: Jiao, Xue, et al.
Publicado: (2021)

Unsupervised cluster analysis of clinical and metabolite characteristics in patients with chronic complications of T2DM: an observational study of real data
por: Wang, Cuicui, et al.
Publicado: (2023)

Vascular Endothelial Function as a Valid Predictor of Variations in Pulmonary Function in T2DM Patients Without Related Complications
por: Tai, He, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4cc2ggj86u69eha6n1gp4hqa6d